Research projects
Start of main content
Significance of brain glucose hypometabolism and of altered insulin signal transduction in an experimental model of amiotrophic lateral esclerosis (ALE)
19th national competition for scientific and technical research
Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS): Molecular Etiology and Novel Treatments
Senior Researcher : Enrique Blázquez Fernández
Research Centre or Institution : Universidad Complutense de Madrid
Abstract
Such as brain glucose hypometabolism (BGH), oxidative stress, neuroinflammation and insulin resistance (RI) are pathogenic alterarions present in several neurodegnerative diseases with distinct aethiologies. Accordingly we propose to investigate the possible metabolic alterations in the lateral amyotrophic sclerosis of the TDP43 mice as an experimental model of this disease. Previously we had reported a BGH and RI in mice with tauothopathy, findings of great interest to investigate the effects of several drugs on these alterations. Related with the TDP-43 mice we found a tendency to increase brain glucose metabolism as compared with the wild type (WT) animals, that in females was statistically significant in the brain stem and cerebellum. Related with the genic expresión we found differences between male and female TDP-43 mice. In fact in the hippocampus of female mice we observed an increase of the Slc2a3 and Mtor genes expresion with a negative feedback for the Gsk3 and Pik3r1 genes, while no changes were detected for Akt and Irs1 ones. These findings are probably related with an increase of the anaerobic glycolysis, which is also present in the Parkinson, Alzheimer and Huntington diseases. In mice with tauothopathy an insulin resistance was found, which improves after metformin treatment. Also, in TDP-43 mice the resistance to insulin was determined after the i.p. glucose overload and according with the HOMA procedure. In the case that alterations can be found, the mice will be treated with metformin, exenatide or literaglutide. Finally a signicant part of our work at the end of this scientific project has been dedicated in writting and processing the publication of several papers.
Scientific Production |
|
---|---|
Magazine Articles | 7 |
Communications at national conferences | 3 |
Communications at international conferences | - |
- Activities related
- Projects related
- News related
- Publications related
-
22
Jun
2022
International Symposium Cuidados paliativos globales: retos y expectativas futuras Madrid, Wednesday, 22 June 2022, 16:00 hours
-
27
Oct
2022
Scientific Symposium Mecanismos de muerte celular en la ELA: posibilidades para el manejo clínico de la enfermedad. VI Encuentro internacional de la ELA en España Madrid, Thursday, 27 October 2022, 16:00 hours
-
4
Oct
2023
Session VII International ALS meeting in Spain: 30 years learning about ALS: new scenarios and challenges Madrid, Wednesday, 4 October 2023, 16:00 hours
- Investigation on hybrid molecules as powerful novel therapeutic approaches for Multiple Sclerosis and myelin- related rare diseases 2018 Senior Researcher : Fernando de Castro Soubriet Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
- Progression of different forms of multiple sclerosis related to the stem/progenitor cells potential 2018 Senior Researcher : Laura López Mascaraque Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
- Functional characterization and mechanisms of the signalling kinase MOK in neuroinfiammation associated to Amyotrophic Lateral Sclerosis (ALS) 2018 Senior Researcher : Cintia Roodveldt Research Centre or Institution : Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)
End of main content